Darius Kharabi
Corporate Officer/Principal presso KALA BIO, INC.
Patrimonio netto: 100 807 $ in data 31/05/2024
Posizioni attive di Darius Kharabi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KALA BIO, INC. | Corporate Officer/Principal | 15/11/2021 | - |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Direttore/Membro del Consiglio | 01/11/2017 | - |
| Presidente | 01/10/2015 | 01/11/2017 | |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Amministratore Delegato | 01/08/2019 | - |
| Direttore Finanziario/CFO | 01/08/2019 | - | |
| Segretario Aziendale | 01/08/2019 | - | |
| Direttore operativo | 01/10/2015 | 01/08/2019 | |
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Fondatore | - | - |
Storia della carriera di Darius Kharabi
Precedenti posizioni note di Darius Kharabi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Amministratore Delegato | 01/08/2018 | 01/12/2021 |
| Direttore Finanziario/CFO | 01/08/2018 | 01/12/2021 | |
| Presidente | 01/08/2018 | 01/12/2021 | |
OrthAlign Corp.
 OrthAlign Corp. Medical SpecialtiesHealth Technology OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA. | Corporate Officer/Principal | 01/06/2009 | - |
Formazione di Darius Kharabi
| Stanford University | Graduate Degree |
| Georgetown University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
Posizioni
| Corporate Officer/Principal | 2 |
| President | 2 |
| Chief Executive Officer | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
OrthAlign Corp.
OrthAlign Corp. Medical SpecialtiesHealth Technology OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA. | Health Technology |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Finance |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
xCella Biosciences, Inc.
xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Health Technology |
Combangio, Inc.
Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Commercial Services |
- Borsa valori
- Insiders
- Darius Kharabi
- Esperienza
